Attenuation of risperidone-induced hyperprolactinemia with the addition of aripiprazole
| Autor: | C. A. Ross, Michelle Rainka, H. A. Capote, Francis M. Gengo |
|---|---|
| Rok vydání: | 2009 |
| Předmět: |
Male
medicine.medical_specialty Impulse control disorder medicine.drug_class medicine.medical_treatment Aripiprazole Atypical antipsychotic Quinolones Partial agonist Piperazines Internal medicine medicine Humans Pharmacology (medical) Antipsychotic Pharmacology Risperidone Receptors Dopamine D2 business.industry fungi Dopamine antagonist food and beverages Middle Aged medicine.disease Hyperprolactinemia Developmental disorder Endocrinology business medicine.drug |
| Zdroj: | Journal of Clinical Pharmacy and Therapeutics. 34:595-598 |
| ISSN: | 1365-2710 0269-4727 |
| DOI: | 10.1111/j.1365-2710.2008.01009.x |
| Popis: | Hyperprolactinemia can be a complication of conventional neurolepics as well as risperidone. We report the third case of attenuation of risperidone-induced hyperprolactinemia by aripiprazole. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|